Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00146848 · ClinicalTrials.gov registry record · Phase 4
PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy
A Phase 4 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,742
- Enrollment target
NCT00146848: Completed Phase 4 study, sponsored by Boston Scientific Corporation.
NCT00146848 is a Phase 4 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,742 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (236% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00146848, a Phase 4 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,742 participants
- Enrollment target
Study Summary
This study will look at different pacing modes (how a device is programmed to pace one's heart), and how these modes may assist in one's daily activities and how one is feeling.
Primary Outcome
The primary outcome measure classified patients as improved, unchanged or worsened, based on a 4 components clinical composite score using the following four components: death, heart failure hospitalization, New York Heart Association \[NYHA\] class, patient's Global Assessment rating. Best value is improved, whereas worst value is worsened.
Interventions
- DEVICE Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,742 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 4 |
What the finished NCT00146848 record still lists
NCT00146848 is an interventional study that assigns participants to a tested intervention. Its 1,742 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (236% higher).
The record links to 0 conditions, and to 1 intervention - of which Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices is the first listed.
NCT00146848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00146848 about?
NCT00146848 is a clinical study titled "PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy". This study will look at different pacing modes (how a device is programmed to pace one's heart), and how these modes may assist in one's daily activities and how one is feeling.
What is the current status of trial NCT00146848?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,742 participants. The study started on 2004-12. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00146848?
The interventions under investigation include: Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices (DEVICE).
Who is sponsoring clinical trial NCT00146848?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00146848's enrollment target sits among peer trials
1,742 45th of 2000 higher than 1,956 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04712656 · 1,739 participants
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- NCT07183527 · 1,750 participants · NA
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia